Inhibiting inflammation in adipocytes accelerates mammary tumor development in mice

Area of Science:

• Oncology
• Immunology
• Metabolic Research

Background:

• Adipocyte (fat cell) inflammation is crucial for healthy adipose tissue function.
• Mammary tumors develop within a complex microenvironment involving various cell types.

Purpose of the Study:

• To investigate the impact of cell type-specific inflammation suppression on mammary tumor development.
• To differentiate the roles of adipocyte versus mammary epithelial cell inflammation in breast cancer progression.

Main Methods:

• Utilized a mammary tumor mouse model (MMTV-PyMT) with cell type-specific expression of the anti-inflammatory RIDα/β protein complex.
• Suppressed inflammation in adipocytes (PyMT-RIDad mice) or mammary epithelial cells (RIDMMTV mice).
• Analyzed tumor onset, growth, metastasis, immune cell infiltration, and molecular markers.

Main Results:

• Suppression of adipocyte inflammation accelerated tumor onset, growth, and metastasis, increasing tumor-associated macrophages and upregulating immunoregulatory molecules.
• Adipocyte inflammation suppression led to metabolic dysfunction and abnormal mammary gland development.
• Mammary epithelial cell inflammation suppression decelerated tumor growth without affecting onset or macrophage levels.
• Tumors in PyMT-RIDad mice showed increased CD36 expression, indicating enhanced fatty acid uptake.

Conclusions:

• Adipocyte inflammation suppression promotes a pro-tumorigenic microenvironment, driving mammary cancer progression.
• Targeting inflammation in different cell types within the mammary gland has distinct effects on tumor development.
• Adipocyte-derived inflammation plays a critical role in breast cancer pathogenesis.